Global 3D Cell Culture Market Capitalizes on Rising Level of Adoption in Research Settings

Cell culture in two dimension (2D) has been undertaken persistently in research laboratories across the globe over the past many decades. However, this arguably traditional method does not reproduce the exact cellular characteristics and behavior of a tissue, leading to data that is not informative or useful enough to promote the understanding of cellular behavior. This factor has prompted an increased level of adoption of three-dimensional cell culture, the cell culture model that helps in promoting levels of tissue organization and cell differentiation not typically possible in the conventional 2D cell culture setting.

For several years now stem cell scientists, tissue engineers, cell biologists, cancer researchers, and the likes are preferring 3D cell culture to enjoy benefits of better data with revolutionary progress in the knowledge regarding the behavior of tissues and cancers. The global 3D cell culture market is projected to expand at an impressive 29.1% CAGR over the period between 2015 and 2020, states a research report published by Persistence Market Research. According to the study, the market will rise from a valuation of US$586.1 mn in 2014 to US$2,717.6 mn by 2020, gaining impetus from the rising level of adoption of these systems in biopharmaceutical and biotechnology companies, hospitals, and research settings.

Rapid Development of 3D Cell Culture Tools Will Boost Market

3D cell culture methods were earlier considered laborious, messy, expensive, and difficult to adapt. These factors were limiting their adoption across price-sensitive regional markets. With time, however, a wide range of 3D cell culture tools entered the market, ranging from simple systems to complex ones. This made their large scale adoption possible on a global level. The market currently boasts a wide array of 3D cell culture system options, which subsequently aids expansion of the global 3D cell culture market.

The wide range of 3D cell culture systems available in the market include microchips, extracellular matrices, extracellular matrices or scaffolds, gels, bioreactors and scaffold-free platforms. Of these, the segment of scaffolds is currently the largest market segment. Of the major end users of 3D cell culture, biotechnology and biopharmaceutical industries lead in terms of demand for 3D cell culture systems.

From a geographical standpoint, Europe is currently the largest market for 3D cell culture. The market for 3D cell culture in Europe is primarily driven by the continuously increasing investment on research and development, rising research activities, and the ability of 3D cell culture systems of replacing animals in pharmaceutical testing and research activities.

Rising Demand for Laboratory Automation Provides Lucrative Growth Opportunity

Laboratory automation is one of the major trends observed in the global 3D cell culture market since the past few years. This is expected to open several lucrative growth opportunities for companies operating in the global 3D cell culture market. Some of the key vendors in the market are Sigma-Aldrich Corporation, Becton, Thermo Fisher Scientific, Inc., 3D Biomatrix, Inc., Corning Incorporated, InSphero AG, Dickinson and Company, Global Cell Solutions, Inc., 3D Biotek LLC, Reinnervate Ltd, and Lonza Group.